PTPN6 and neoplasm: A further factor to consider is that PTPN6 recruitment to CAR cytosolic signalling domains appears to selectively impede T cell inflammatory cytokine production, and thereby reduce the incidence of cytokine release syndrome without impeding anti-tumour activity [75].